These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 17968932)

  • 1. Deficiency of the type I interferon receptor protects mice from experimental lupus.
    Nacionales DC; Kelly-Scumpia KM; Lee PY; Weinstein JS; Lyons R; Sobel E; Satoh M; Reeves WH
    Arthritis Rheum; 2007 Nov; 56(11):3770-83. PubMed ID: 17968932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus.
    Lee PY; Kumagai Y; Li Y; Takeuchi O; Yoshida H; Weinstein J; Kellner ES; Nacionales D; Barker T; Kelly-Scumpia K; van Rooijen N; Kumar H; Kawai T; Satoh M; Akira S; Reeves WH
    J Exp Med; 2008 Dec; 205(13):2995-3006. PubMed ID: 19047436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
    Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
    Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus.
    Thibault DL; Graham KL; Lee LY; Balboni I; Hertzog PJ; Utz PJ
    Arthritis Res Ther; 2009; 11(4):R112. PubMed ID: 19624844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons.
    Reeves WH; Lee PY; Weinstein JS; Satoh M; Lu L
    Trends Immunol; 2009 Sep; 30(9):455-64. PubMed ID: 19699150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR9 Deficiency Leads to Accelerated Renal Disease and Myeloid Lineage Abnormalities in Pristane-Induced Murine Lupus.
    Bossaller L; Christ A; Pelka K; Nündel K; Chiang PI; Pang C; Mishra N; Busto P; Bonegio RG; Schmidt RE; Latz E; Marshak-Rothstein A
    J Immunol; 2016 Aug; 197(4):1044-53. PubMed ID: 27354219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Th17-Associated Interstitial Kidney Inflammation in Lupus-Prone Mice Lacking the Gene Encoding STAT-1.
    Yiu G; Rasmussen TK; Ajami B; Haddon DJ; Chu AD; Tangsombatvisit S; Haynes WA; Diep V; Steinman L; Faix J; Utz PJ
    Arthritis Rheumatol; 2016 May; 68(5):1233-44. PubMed ID: 26636548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.
    Savarese E; Steinberg C; Pawar RD; Reindl W; Akira S; Anders HJ; Krug A
    Arthritis Rheum; 2008 Apr; 58(4):1107-15. PubMed ID: 18383384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice.
    Richards HB; Satoh M; Jennette JC; Okano T; Kanwar YS; Reeves WH
    Clin Exp Immunol; 1999 Mar; 115(3):547-53. PubMed ID: 10193432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease.
    Agrawal H; Jacob N; Carreras E; Bajana S; Putterman C; Turner S; Neas B; Mathian A; Koss MN; Stohl W; Kovats S; Jacob CO
    J Immunol; 2009 Nov; 183(9):6021-9. PubMed ID: 19812195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the immune response in pristane-induced lupus by expression of activation and inhibitory Fc receptors.
    Clynes R; Calvani N; Croker BP; Richards HB
    Clin Exp Immunol; 2005 Aug; 141(2):230-7. PubMed ID: 15996187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Mechanism for Generating the Interferon Signature in Lupus: Opsonization of Dead Cells by Complement and IgM.
    Zhuang H; Han S; Li Y; Kienhöfer D; Lee P; Shumyak S; Meyerholz R; Rosadzinski K; Rosner D; Chan A; Xu Y; Segal M; Sobel E; Yang LJ; Hoffmann MH; Reeves WH
    Arthritis Rheumatol; 2016 Dec; 68(12):2917-2928. PubMed ID: 27274010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel type I IFN-producing cell subset in murine lupus.
    Lee PY; Weinstein JS; Nacionales DC; Scumpia PO; Li Y; Butfiloski E; van Rooijen N; Moldawer L; Satoh M; Reeves WH
    J Immunol; 2008 Apr; 180(7):5101-8. PubMed ID: 18354236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17 promotes murine lupus.
    Amarilyo G; Lourenço EV; Shi FD; La Cava A
    J Immunol; 2014 Jul; 193(2):540-3. PubMed ID: 24920843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-IFNAR treatment does not reverse neuropsychiatric disease in MRL/
    Huang MW; Stock AD; Mike EV; Herlitz L; Kolbeck R; Putterman C
    Lupus; 2019 Nov; 28(13):1510-1523. PubMed ID: 31474191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell proliferation, somatic hypermutation, class switch recombination, and autoantibody production in ectopic lymphoid tissue in murine lupus.
    Nacionales DC; Weinstein JS; Yan XJ; Albesiano E; Lee PY; Kelly-Scumpia KM; Lyons R; Satoh M; Chiorazzi N; Reeves WH
    J Immunol; 2009 Apr; 182(7):4226-36. PubMed ID: 19299721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief Report: Vitamin D Deficiency Is Associated With Endothelial Dysfunction and Increases Type I Interferon Gene Expression in a Murine Model of Systemic Lupus Erythematosus.
    Reynolds JA; Rosenberg AZ; Smith CK; Sergeant JC; Rice GI; Briggs TA; Bruce IN; Kaplan MJ
    Arthritis Rheumatol; 2016 Dec; 68(12):2929-2935. PubMed ID: 27390112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 7-stimulated tumor necrosis factor α causes bone marrow damage in systemic lupus erythematosus.
    Zhuang H; Han S; Xu Y; Li Y; Wang H; Yang LJ; Reeves WH
    Arthritis Rheumatol; 2014 Jan; 66(1):140-51. PubMed ID: 24449581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus.
    Xu Y; Lee PY; Li Y; Liu C; Zhuang H; Han S; Nacionales DC; Weinstein J; Mathews CE; Moldawer LL; Li SW; Satoh M; Yang LJ; Reeves WH
    J Immunol; 2012 Apr; 188(8):4113-21. PubMed ID: 22422888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.